Recent Articles from GlobeNewswire

China's Gen-III+ Advanced Nuclear Power Technology "Hualong One" 2.0 Unveiled to the Global Market
CGN
By CGN · Via GlobeNewswire · September 9, 2026
Kaplan Fox Alerts EquipmentShare.Com Inc (NASDAQ: EQPT) Investors to a Securities Fraud Lawsuit – Lead Plaintiff Deadline is September 21, 2026
NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against EquipmentShare.Com Inc (“EquipmentShare” or the “Company”) (NASDAQ: EQPT) on behalf of investors who purchased or otherwise acquired EquipmentShare common stock pursuant and/or traceable to the Company’s initial public offering on or around January 23, 2026 (the “IPO”), or between January 23, 2026 and June 23, 2026 (the “Class Period”).
By Kaplan Fox & Kilsheimer, LLP · Via GlobeNewswire · September 9, 2026
American Academy of Neurology onboards Marvix AI to its Practice Success Network to bring ambient AI to thousands of neurologists
BOSTON, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Marvix AI, an ambient AI scribe for neurology today announced American Academy of Neurology (AAN), the world’s largest association of neurologists and neuroscience professionals, will now be part of its exclusive Practice Success Network (PSN). Marvix AI is one of the few companies that is chosen to be part of this selective program and will be able to bring its advanced Ambient AI offerings to neurologists across the country. Neurology groups and practices will be able to avail a 30-day free trial with full customizations and integration with their existing EHRs.
By Marvix AI, Inc. · Via GlobeNewswire · September 9, 2026
From American Forests to the Architect’s Material Library
Lunawood Hardwood Samples Now Available on Material Bank
By Oy Lunawood Ltd · Via GlobeNewswire · September 9, 2026
Hudbay Recognized as a Top Performer by the Toronto Stock Exchange with Inclusion in the TSX30
TORONTO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) is proud to be recognized as a 2026 TSX30™ winner by the Toronto Stock Exchange (TSX). The annual ranking recognizes the top 30 performing stocks over a three-year period. Hudbay’s share price increased 427% over this period.
By Hudbay Minerals Inc. · Via GlobeNewswire · September 9, 2026
Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York
CEO Michael Halstead to participate in a fireside chat on Monday, September 14, 2026 at 9:00 a.m. EDT
By Helus Pharma · Via GlobeNewswire · September 9, 2026
XCharge Regains Compliance with Nasdaq Minimum Bid Price Requirement
HAMBURG, Germany and AUSTIN, Texas, Sept. 09, 2026 (GLOBE NEWSWIRE) -- XCHG Limited (“XCharge” or the “Company”) (Nasdaq: XCH), a global provider in high-power EV charging solutions, today announced that the Company received a written compliance notification (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on September 8, 2026, informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”) for continued listing on Nasdaq.
By XCHG LIMITED · Via GlobeNewswire · September 9, 2026
FTI Consulting Strengthens Construction Disputes Capabilities in Latin America With Appointment of Luis Roman
Construction Forensics Expert Brings More Than 30 Years of Construction and Project Management Experience
By FTI Consulting, Inc. · Via GlobeNewswire · September 9, 2026
Kaplan Fox Announces a Securities Class Action Filed Against GPGI, Inc. (NYSE: GPGI) – Lead Plaintiff Deadline is September 14, 2026
NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against GPGI, Inc. f/k/a CompoSecure, Inc. (NYSE: GPGI) (NYSE: CMPO) on behalf of investors that purchased or otherwise acquired GPGI Class A common stock between November 3, 2025 and May 6, 2026 (the “Class Period”).
By Kaplan Fox & Kilsheimer, LLP · Via GlobeNewswire · September 9, 2026
Hammond Power Solutions Included in 2026 TSX30 Ranking
GUELPH, Ontario, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Hammond Power Solutions Inc. (“HPS”) (TSX: HPS.A) a leading manufacturer of dry-type transformers and power quality solutions, announced their inclusion in the 2026 TSX30 ranking, highlighting the top-performing companies on the Toronto Stock Exchange.
By Hammond Power Solutions Inc · Via GlobeNewswire · September 9, 2026
Palvella Therapeutics Appoints James R. Treat, M.D., Nationally Recognized Pediatric Dermatologist as Chief Medical Officer
Brings expertise in cutaneous vascular anomalies, including microcystic lymphatic malformations, venous malformations and angiokeratomas
By Palvella Therapeutics Inc. · Via GlobeNewswire · September 9, 2026
Abaxx Exchange LNG Futures Reach New Monthly Volume Highs in August 2026
TORONTO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (TSX:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), today reported August 2026 trading results, including new monthly volume highs in Gulf of Mexico (GOM) and North Pacific Asia (NPA) LNG futures.
By Abaxx Technologies Inc. · Via GlobeNewswire · September 9, 2026
America's Car-Mart Reports First Quarter Fiscal Year 2027 Results
ROGERS, Ark., Sept. 09, 2026 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) (“we,” “Car-Mart” or the “Company”), today reported financial results for the first quarter ended July 31, 2026.
By America's Car-Mart, Inc. · Via GlobeNewswire · September 9, 2026
NervGen to Host Inaugural R&D Day on September 30, 2026
VANCOUVER, British Columbia, Sept. 09, 2026 (GLOBE NEWSWIRE) -- NervGen (NASDAQ: NGEN), a late-stage clinical biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions, today announced that it will host its inaugural R&D Day webcast on Wednesday, September 30, 2026, from 10:00 a.m. to 12:00 p.m. ET.
By NervGen Pharma Corp. · Via GlobeNewswire · September 9, 2026
Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202
CT-202 is a Nectin-4 x CD3 T cell engaging bispecific antibody
By Context Therapeutics Inc. · Via GlobeNewswire · September 9, 2026
Orion180 Insurance Group Inc. Announces Launch of Initial Public Offering
MELBOURNE, Fla., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Orion180 Insurance Group Inc. ("Orion180"), a leading provider of flexible, customer-centric homeowners and flood insurance solutions, today announced that it has launched the roadshow for its proposed initial public offering of its Class A common stock. Orion180 has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") to offer 20,000,000 shares of its Class A common stock to the public. In addition, Orion180 intends to grant the underwriters a 30-day option to purchase up to an additional 3,000,000 shares of Class A common stock at the initial public offering price, less underwriting discounts and commissions. The initial public offering price is expected to be between $15.00 and $17.00 per share. Orion180 has applied to list its Class A common stock on the Nasdaq Global Select Market under the ticker symbol "OIG."
By Orion180 · Via GlobeNewswire · September 9, 2026
Six in 10 Organizations Experienced at Least One Material Cyberattack in the Past 18 Months
New research commissioned by TransUnion highlights organizations’ incident response vulnerabilities
By TransUnion · Via GlobeNewswire · September 9, 2026
Kaplan Fox Announces a Securities Class Action Filed Against Planet Fitness, Inc. (NYSE: PLNT) – Lead Plaintiff Deadline is September 14, 2026
NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Planet Fitness, Inc. (“Planet Fitness” or the “Company”) (NYSE: PLNT) on behalf of investors that purchased or otherwise acquired Planet Fitness securities between November 6, 2025 and May 6, 2026 (the “Class Period”).
By Kaplan Fox & Kilsheimer, LLP · Via GlobeNewswire · September 9, 2026
CRB Names Helga Margrethe Salling Chief Growth Officer
Industry leader to advance CRB’s growth strategy as life sciences manufacturers face rising complexity, capital pressure and speed-to-market decisions
By CRB Group, Inc. · Via GlobeNewswire · September 9, 2026
Directive Launches Expanded Communications Division, Bringing Performance Principles to B2B PR, Social and Influencer Marketing
Directive’s expansion reflects growing B2B demand to move upstream into brand and communications to influence demand
By Directive · Via GlobeNewswire · September 9, 2026
U.S. Critical Minerals enters into agreements to merge with Nova Resources and acquire the historic McAllister tantalum mine and mill in Alabama
Signed agreements cover a historic U.S. tantalum asset and existing processing infrastructure with a district-scale lithium-cesium-tantalum exploration position
By U.S. Critical Minerals, LLC. · Via GlobeNewswire · September 9, 2026
SailPoint Announces Fiscal Second Quarter 2027 Results
AUSTIN, Texas, Sept. 09, 2026 (GLOBE NEWSWIRE) -- SailPoint, Inc. (Nasdaq: SAIL), a leader in enterprise identity security, today announced financial results for its fiscal second quarter ended July 31, 2026.
By SailPoint Technologies, Inc. · Via GlobeNewswire · September 9, 2026
Can-Fite: Publication Reports Improvement in Decompensated Cirrhosis with Namodenoson and Successful Bridging to Liver Transplantation
Patient Experienced Resolution of Ascites, Regression of Esophageal Varices and Remained Clinically Stable for Approximately 28 Months Prior to Successful Liver Transplantation
By Can-Fite BioPharma Ltd. · Via GlobeNewswire · September 9, 2026
Amplify ETFs Recognized with Two 2026 ETF Express Award Nominations
Firm Earns Repeat Recognition for Crypto Innovation and Options Strategy Leadership
By Amplify ETFs · Via GlobeNewswire · September 9, 2026
Autolus Therapeutics Announces FDA RMAT Designation Granted to Obe-cel for the Treatment of Systemic Lupus Erythematosus and Lupus Nephritis
Enrollment in LUMINA, the pivotal Phase 2 study of obe-cel in refractory lupus nephritis, is ongoing
By Autolus Therapeutics plc · Via GlobeNewswire · September 9, 2026
Copper Giant Resources Corp. Begins Trading on OTCQX Best Market
NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Copper Giant Resources Corp. (TSX-V: CGNT; OTCQX: CGNRF), a mineral exploration company, has qualified to trade on the OTCQX® Best Market. Copper Giant Resources Corp. upgraded to OTCQX from the OTCQB® Venture Market.
By OTC Markets · Via GlobeNewswire · September 9, 2026
Destination XL Group, Inc. Reports Second Quarter Financial Results
Sales of $111.6 million, Net Income of $0.04 per diluted share, Adjusted Net Income of $0.05 per diluted share 
By Destination XL Group, Inc. · Via GlobeNewswire · September 9, 2026
Onco360® Has Been Selected as Part of an Ultra-Narrow Specialty Pharmacy Network for MIMRYLO™ (rusfertide)
LOUISVILLE, Ky., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected by Takeda Pharmaceuticals as an ultra-narrow limited distribution partner for MIMRYLO™ (rusfertide), which is indicated for the treatment of erythrocytosis in adults with polycythemia vera (PV).1
By Onco360 Oncology Pharmacy · Via GlobeNewswire · September 9, 2026
LifeStance Health Group Announces Launch of Secondary Public Offering
SCOTTSDALE, Ariz., Sept. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced that pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”), certain stockholders of the Company (the “Selling Stockholders”) intend to offer 22,250,000 shares of LifeStance’s common stock, par value $0.01 per share (the “Common Stock”). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive any proceeds from the offering.
By LifeStance Health, Inc. · Via GlobeNewswire · September 9, 2026
CoinShares CEO Jean-Marie Mognetti to Attend Oppenheimer Fintech Leaders Conference in New York
JERSEY, Channel Islands — September 9, 2026 — CoinShares PLC (Nasdaq: CSHR) ("CoinShares" or the "Company"), a leading global asset manager specializing in digital assets, today announced that President and Chief Executive Officer Jean-Marie Mognetti will attend the Oppenheimer Fintech Leaders Conference in New York, taking place September 15, 2026.
By CoinShares PLC · Via GlobeNewswire · September 9, 2026
Troilus Reports Updated Technical Report Following Completion of Basic Engineering, Delivering After-Tax US$3.2 Billion NPV5%, 22% IRR, and Cashflow of US$6.9 Billion at Base Case Gold Price of US $3,600/oz
Approximately 95,000 engineering hours and market validation of ~90% of pricing underpin AACE Class 3 estimate accuracy across the full Project scope
By Troilus Mining Corp. · Via GlobeNewswire · September 9, 2026
Broncos Country, This One’s for You: Breckenridge Distillery Kicks Off Another Season with the Denver Broncos and a Limited-Edition Whiskey Collection Honoring “The Drive”
Celebrating six seasons as a proud whiskey partner of the Denver Broncos, Breckenridge Distillery debuts a limited-edition Bourbon Whiskey lineup and Creamsicle Whiskey Seltzer built for Broncos Country, game-day traditions, and one of football’s most iconic moments
By Tilray Brands, Inc. · Via GlobeNewswire · September 9, 2026
Xanadu and ASML Announce Collaboration to Advance Lithography for Photonic Quantum Hardware
TORONTO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Xanadu Quantum Technologies Limited ("Xanadu"; NASDAQ/TSX: XNDU), a leading photonic quantum computing company, and ASML, a leading supplier to the semiconductor industry, today announced a collaboration to develop advanced lithography processes for Xanadu’s photonic quantum hardware. This collaboration aims to enable both companies to gain deeper insight into how advanced lithography innovations can help reduce optical losses in quantum computing chips, accelerating the industry's path toward utility-scale quantum computing (USQC).
By Xanadu Quantum Technologies Limited · Via GlobeNewswire · September 9, 2026
MapLight Therapeutics to Participate in Upcoming Investor Conference
SAN FRANCISCO and BOSTON, Sept. 09, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT) today announced that members of its management team will participate in the following investor conference:
By MapLight Therapeutics, Inc. · Via GlobeNewswire · September 9, 2026
Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)
MICVO demonstrated rapid and deep responses, with a 36% confirmed objective response rate (cORR) and 94% disease control rate (DCR), with clinical activity observed across HPV status and prior-treatment subgroups
By Pyxis Oncology · Via GlobeNewswire · September 9, 2026
Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026
MONTVALE, N.J., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference.
By Balchem Corporation · Via GlobeNewswire · September 9, 2026
Accumulus Technologies Announces Acquisition by Eir Partners to Accelerate Next Phase of Growth
Strategic investment will support continued advancement of the Accumulus platform and expand global adoption across the life sciences regulatory ecosystem
By Accumulus Technologies · Via GlobeNewswire · September 9, 2026
Fractyl Health to Participate in Upcoming September Investor Conferences
BURLINGTON, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D), today announced that Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer of the Company, will be participating in the following upcoming investor conferences:
By Fractyl Health, Inc. · Via GlobeNewswire · September 9, 2026
Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society
IRVINE, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced an oral presentation highlighting the long-term safety and efficacy of tegoprubart in preventing kidney transplant rejection will take place at the upcoming International Congress of The Transplantation Society in Sydney, Australia, from September 20–23, 2026.
By Eledon Pharmaceuticals, Inc. · Via GlobeNewswire · September 9, 2026
Operative Launches Unified Platform to Transform Advertising & Broadcast Management
Connected Agentic Ecosystem Accelerates Revenue Growth For Media Companies In The Agentic Workflow Era
By Operative, Inc. · Via GlobeNewswire · September 9, 2026
OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026
Company to engage with the global ophthalmology and investment community as it advances urcosimod through its global Phase 3 pivotal trial for neuropathic corneal pain
By OKYO Pharma LTD · Via GlobeNewswire · September 9, 2026
Remix Therapeutics Appoints Nicole Sweeny as Chief Commercial Officer
Accomplished Industry Executive to Lead Commercial Strategy and Launch Readiness
By Remix Therapeutics · Via GlobeNewswire · September 9, 2026
Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR – West 2026 Meeting
SAN DIEGO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced clinical data from its off-the-shelf anti-CD19 CAR T-cell product candidate FT819, and pre-clinical data from its off-the-shelf anti-CD19 and CD38 CAR T-cell product candidate FT839 will be featured at the Congress of Clinical Rheumatology West (CCR – West) meeting, being held in Huntington Beach, CA on September 17-20, 2026.
By Fate Therapeutics, Inc. · Via GlobeNewswire · September 9, 2026
Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism
Data from the Phase 3 sunRIZE study remains under review by FDA 
By Rezolute, Inc. · Via GlobeNewswire · September 9, 2026
NEW CHUCK E. CHEESE STATE OF THE BIRTHDAY PARTY REPORT REVEALS WHAT KIDS REALLY WANT FROM THEIR BIRTHDAY PARTIES
As the Birthday Capital of the Universe, Chuck E. Cheese reveals that kids hold real influence over their birthday celebrations and value activities over themes and decorations
By Chuck E. Cheese · Via GlobeNewswire · September 9, 2026
Beeline Medicines Announces Positive Topline Results from Global Phase 2 Study of Afimetoran in Systemic Lupus Erythematosus
– Study met its primary endpoint, with afimetoran demonstrating higher SRI-4 response rates versus placebo at Week 48 (p-value <0.001 across all dose groups) –
By Beeline Medicines Corporation · Via GlobeNewswire · September 9, 2026
SunHydrogen CTO Details Path from Demonstrated Module Performance to Commercialization
Letter to shareholders covers Austin ProtoHub results, CTF Solar manufacturing, Honda R&D efficiency work, and Sparc Hydrogen collaboration
By SUNHYDROGEN, INC. · Via GlobeNewswire · September 9, 2026
Solstice Oncology Launches with $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy
Porustobart, a second-generation Fc-enhanced CTLA-4 antibody, is being advanced across two clinical indications in the neoadjuvant setting, beginning with MSS clinical stage II-III colon cancer
By Solstice Oncology · Via GlobeNewswire · September 9, 2026
ODDITY Tech Reports Second Quarter 2026 Results, Expects Sequential Revenue Improvement in the Third Quarter
NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (NASDAQ: ODD) today announced its financial results for the second quarter ended June 30, 2026.
By Oddity Tech Ltd. · Via GlobeNewswire · September 9, 2026
Invisible Balance Disorders Affect Millions
ASHA Joins National Effort To “Make Vestibular Visible” for September Awareness Week
MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company focused on developing innovative, patient-centric therapies for chronic diseases, and Rose Pharma Inc. (Rose Pharma) today announced that they have entered into a worldwide licensing and collaboration agreement to develop ROSE-010 Technosphere for weight management. ROSE-010 is an investigational, rapid-acting glucagon-like peptide-1 (GLP-1) receptor agonist that will be formulated using MannKind’s proprietary Technosphere dry-powder inhalation technology. The companies intend to evaluate whether a rapid-acting, short-duration inhaled GLP-1 may offer a flexible approach to weight management.
By MannKind · Via GlobeNewswire · September 9, 2026
Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference
MELBOURNE, Australia and INDIANAPOLIS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) advises that Dr. Christian Behrenbruch, Managing Director and Group CEO and Kevin Richardson, CEO, Precision Medicine will present at the upcoming Morgan Stanley 24th Annual Global Healthcare Conference and at the H.C. Wainwright 28th Annual Global Investment Conference, both in New York, NY.
By Telix Pharmaceuticals Limited · Via GlobeNewswire · September 9, 2026
Einride Expands Defense Offering With Mission Planning and Operational Decision-Making for Autonomous Logistics
By Einride AB · Via GlobeNewswire · September 9, 2026
EarthDaily Awarded Government of Canada National Master Standing Offer for Commercial Satellite Imagery
Standing offer establishes a streamlined pathway for Government of Canada to acquire EarthDaily commercial satellite imagery products.
By EarthDaily Analytics · Via GlobeNewswire · September 9, 2026
Kyushu Electric Power Advances Strategic Investment in ProLogium, Deepening Collaboration in Next-Generation Batteries and Energy Sector
Existing collaboration in energy and next-generation batteries expands toward capital participation, further strengthening ProLogium's long-term engagement with Japan's industrial ecosystem
By ProLogium Technology Co., Ltd. · Via GlobeNewswire · September 9, 2026
Sysco Reaffirming Fiscal 2027 Guidance; Introducing $500 Million Multi-Year AI Powered Efficiency Program; Raising Mid-Term Financial Algorithm Targets
HOUSTON, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) (“Sysco” or the “Company”) is reaffirming its fiscal 2027 financial guidance (originally issued on August 4, 2026) ahead of the Company’s webcast presentation from the Barclays 19th Annual Global Consumer Staples Conference in Boston scheduled for today, Wednesday, September 9, at 12:00 p.m. ET. The live conference webcast can be accessed at investors.sysco.com.
By Sysco Corporation · Via GlobeNewswire · September 9, 2026
39th Annual Bigelow Tea Community Challenge Returns to Southport, Connecticut on September 27
Family owned, Certified B Corporation tea company's flagship charity race unites runners, walkers and volunteers to support 21 Connecticut nonprofits
By Bigelow Tea · Via GlobeNewswire · September 9, 2026
Kilbourne Graphite Project Advances Through Key Permitting Milestones
Completion of USACE Public Comment Stage Marks Key Step in Federal Review as State and Environmental Workstreams Progress
By Titan Mining Corporation · Via GlobeNewswire · September 9, 2026
Exceptional El Niño set to deliver an extended fall season to Canada
The Weather Network’s 2026 Fall Forecast
By Pelmorex Corp. · Via GlobeNewswire · September 9, 2026
FreedomPay Launches Commerce Intelligence Offering on Snowflake Marketplace
FreedomPay’s autonomous commerce platform delivers AI-ready reconciliation and analytics
By FreedomPay · Via GlobeNewswire · September 9, 2026
KBR Awarded US Government Contract Delivering Advanced Engineering Radio Frequency Capabilities
HOUSTON, Sept. 09, 2026 (GLOBE NEWSWIRE) -- KBR (NYSE: KBR) announced that its Mission Technology Solutions business, which will become Trinzic following its planned spin-off, has won a three-year contract to continue advancing mission-critical radio frequency engineering and modernization for a U.S. government customer. The award supports the continuity and readiness of essential national security systems. It reinforces KBR’s strategic position as a trusted technology partner, combining deep mission expertise with an outcome-driven approach and rapid execution.
By Kellogg Brown & Root LLC. · Via GlobeNewswire · September 9, 2026
EAIGG and Draup Launch “The AI Sovereignty Paradox,” Introducing a New Framework for Understanding National AI Competitiveness
New report introduces the “AI Sovereignty Paradox,” arguing that long-term AI advantage depends on maintaining strategic control and choice while participating in global AI ecosystems.
Dassault Aviation: Reception of the First Two Falcon Albatros Aircraft by the DGA
Reception of the First Two Falcon Albatros Aircraft by the DGA
By Dassault Aviation · Via GlobeNewswire · September 9, 2026
Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers
Basel, Switzerland and Chassieu, France, , Sept. 09, 2026 (GLOBE NEWSWIRE) --
By Amoeba · Via GlobeNewswire · September 9, 2026
From Smart Pet Hardware to AI-Powered Pet Health Management: PetSuper Showcases the Future of Pet Care at IFA 2026
BERLIN, Sept. 09, 2026 (GLOBE NEWSWIRE) -- PetSuper, a smart pet technology brand focused on developing intelligent products that enhance everyday pet care, made its debut at IFA 2026. Showcasing its connected smart pet portfolio and its evolving vision for an AI-powered smart pet ecosystem, the brand demonstrated how smart hardware, IoT connectivity, everyday care data and PetSuperAi can work together to support more connected and informed pet care.
By PetSuper Smart Technology Co.,Ltd · Via GlobeNewswire · September 9, 2026
Oral Infigratinib Shows Meaningful Benefits Beyond Growth Within 52 Weeks in Children with Achondroplasia in the Phase 3 PROPEL 3 Trial
- Treatment with oral infigratinib for 52 weeks in PROPEL 3 resulted in favorable trends against placebo in clinically meaningful exploratory endpoints including sleep apnea and otitis media events
By BridgeBio Pharma, Inc. · Via GlobeNewswire · September 9, 2026
At IFA 2026, TORRAS puts phone cases to work beyond drop protection
Hands-on trials of the Q3 Air Pro highlighted TORRAS's push to expand phone cases beyond protection into viewing, navigation and filming
By TORRAS · Via GlobeNewswire · September 9, 2026
KAXFREE Showcases Smart Home Coffee Innovations at IFA 2026
BERLIN, Sept. 09, 2026 (GLOBE NEWSWIRE) -- At IFA 2026, KAXFREE showcased a smart home coffee portfolio shaped by KALERM Group’s 16 years of commercial coffee-machine experience. At Hall 8.1, Booth 224, demonstrations and tastings highlighted its adaptation for home use.
Ensurge Micropower Relocates to New San Jose Facility to Advance Solid-State Microbattery Development
New building will accelerate pilot-line capabilities and customer engagement while reducing facility overhead from 30% to 10% of monthly operating expenses
By Ensurge Micropower Inc. · Via GlobeNewswire · September 9, 2026
Zscaler launches Agentic SOC to contain AI-Driven Threats
Unifying exposure management and SOC workflows with Zscaler telemetry and specialized AI agents that detect, investigate, and respond to threats at machine speed
By Zscaler, Inc. · Via GlobeNewswire · September 9, 2026
Percona Releases 2026 State of Open Source Database Management Report: Control and Flexibility Emerge as Strategic Priorities
New research finds 54% say vendor lock-in makes it difficult to adapt to changing regulatory requirements as cloud costs, AI workloads, and infrastructure complexity rise
By Percona · Via GlobeNewswire · September 9, 2026
Launch of StoneX Trading marks a new era for City Index
LONDON, Sept. 09, 2026 (GLOBE NEWSWIRE) -- StoneX Group Inc. (NASDAQ: SNEX) today announced that City Index, one of UK’s most established trading brands, is relaunching as StoneX Trading.
By StoneX Group Inc. · Via GlobeNewswire · September 9, 2026
82% of Organizations Had to Explain an Identity Decision, and One-Third Could Provide Only Limited Evidence
RESTON, Va., Sept. 09, 2026 (GLOBE NEWSWIRE) -- 82% of organizations have been asked to document or explain an identity-related decision to a regulator, court, or external auditor, according to a global study by Regula of 850 fraud prevention and financial crime decision-makers. Among that group, 32% could provide only limited or indirect evidence, making it harder to defend decisions, investigate fraud, resolve disputes, and demonstrate compliance.
By Regula Forensics · Via GlobeNewswire · September 9, 2026
MulticoreWare and Micware Sign MOU to Explore Potential Collaboration in ADAS Performance Optimization and Physical AI at the Edge
KOBE, Japan, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Micware Co., Ltd. (Nasdaq: MWC) (the “Company” or “Micware”), a Japan-based provider of software development services and innovative IT solutions mainly focused on the automotive and mobility sectors, today announced the signing of a Memorandum of Understanding (“MOU”) with MulticoreWare, Inc. (“MultiCoreWare”) to explore potential collaboration on next-generation artificial intelligence (“AI”) solutions, with a focus on advanced driver assistance systems (“ADAS”) performance optimization and integration, AI-powered in-vehicle user experience, and physical AI at the edge.
By Micware Co., Ltd. · Via GlobeNewswire · September 9, 2026
Allegro’s Hydrocelin significantly improves knee osteoarthritis pain and function in clinical trial
Liege, Belgium – 9 September 2026 (08:30 CET) – Allegro NV, a biomedical company developing a transformative nanotechnology treatment for osteoarthritis, today announced statistically significant improvements in pain and function endpoints over 6-months from an ongoing clinical study with Hydrocelin in 30 patients with knee osteoarthritis.
By Allegro NV · Via GlobeNewswire · September 9, 2026
Articles from GlobeNewswire | MarketMinute